Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Alment Praktiserende Læge Isabel Zanjani ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   5.5% 5.6% 5.7% 5.1% 2.2% 3.6% 6.0% 6.0%   Credit score (0-100)   43 42 40 42 65 51 39 39   Credit rating   BBB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 -0.0 -0.0 -0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -58.2 12.8 -75.1 -57.9 -17.0 -54.7 0.0 0.0   EBITDA   -222 -606 -649 -722 -368 -727 0.0 0.0   EBIT   -270 -706 -751 -835 -494 -903 0.0 0.0   Pre-tax profit (PTP)   149.3 -80.7 139.7 -107.7 463.6 148.2 0.0 0.0   Net earnings   115.6 -63.2 108.2 -89.9 360.6 79.1 0.0 0.0   Pre-tax profit without non-rec. items   149 -80.7 140 -108 464 148 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   86.6 92.5 133 118 72.8 69.5 0.0 0.0   Shareholders equity total   166 48.5 157 66.8 427 389 217 217   Interest-bearing liabilities   1,629 1,397 1,266 1,342 932 1,606 1,983 1,983   Balance sheet total (assets)   2,138 1,767 1,608 1,512 1,528 2,284 2,200 2,200   Net Debt   1,442 1,360 1,264 1,342 931 1,606 1,983 1,983     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -58.2 12.8 -75.1 -57.9 -17.0 -54.7 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 22.9% 70.6% -222.0% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,138 1,767 1,608 1,512 1,528 2,284 2,200 2,200   Balance sheet change%   0.0% -17.3% -9.0% -6.0% 1.0% 49.5% -3.7% 0.0%   Added value   -222.0 -606.2 -648.6 -721.9 -380.9 -727.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,549 -172 -290 46 -251 722 -69 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   464.4% -5,509.0% 1,000.3% 1,443.3% 2,907.1% 1,650.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.7% 3.0% 13.8% 2.3% 38.1% 23.8% 0.0% 0.0%   ROI %   13.6% 3.3% 15.1% 2.4% 39.5% 24.6% 0.0% 0.0%   ROE %   69.8% -59.0% 105.5% -80.5% 145.9% 19.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   7.7% 2.7% 9.7% 4.4% 28.0% 17.0% 9.8% 9.8%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -649.4% -224.4% -194.9% -185.9% -252.8% -220.8% 0.0% 0.0%   Gearing %   983.7% 2,884.0% 808.2% 2,009.4% 218.1% 413.1% 915.2% 915.2%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   14.9% 9.2% 7.0% 10.9% 10.2% 24.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.6 1.7 0.6 0.0 0.4 0.0 0.0 0.0   Current Ratio   3.6 1.7 0.6 0.0 0.4 0.0 0.0 0.0   Cash and cash equivalent   187.5 37.3 2.3 0.0 1.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   390.3 95.2 -215.3 -545.7 -257.6 -1,397.8 -991.5 -991.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -222 -606 -649 -722 -381 -727 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -222 -606 -649 -722 -368 -727 0 0   EBIT / employee   -270 -706 -751 -835 -494 -903 0 0   Net earnings / employee   116 -63 108 -90 361 79 0 0